In the latest trading session, 1.67 million Oragenics Inc (AMEX:OGEN) shares changed hands as the company’s beta touched 0.48. With the company’s most recent per share price at $0.94 changing hands around $0.01 or 0.90% at last look, the market valuation stands at $5.24M. OGEN’s current price is a discount, trading about -723.4% off its 52-week high of $7.74. The share price had its 52-week low at $0.86, which suggests the last value was 8.51% up since then. When we look at Oragenics Inc’s average trading volume, we note the 10-day average is 2.69 million shares, with the 3-month average coming to 511.28K.
Oragenics Inc (AMEX:OGEN) trade information
Instantly OGEN is in green as seen in intraday trades today. With action -47.84%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -83.31%, with the 5-day performance at -47.84% in the red. However, in the 30-day time frame, Oragenics Inc (AMEX:OGEN) is -10.58% down. Looking at the short shares, we see there were 42738.0 shares sold at short interest cover period of 0.36 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Oragenics Inc (OGEN) estimates and forecasts
Year-over-year growth is forecast to reach -71.20% down from the last financial year.
The company’s revenue for the corresponding quarters a year ago was 30k and 86k respectively.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 29.34%.
OGEN Dividends
Oragenics Inc is expected to release its next quarterly earnings report on 2023-May-12.
Oragenics Inc (AMEX:OGEN)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 18.65% of Oragenics Inc shares while 7.08% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 8.70%.
Among Mutual Funds, the top two as of Jun 30, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. With 26.39 shares estimated at $24543.0 under it, the former controlled 0.47% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.16% of the shares, roughly 8.87 shares worth around $8244.0.
